Edition:
United Kingdom

People: OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

113JPY
17 Jul 2019
Change (% chg)

¥5 (+4.63%)
Prev Close
¥108
Open
¥108
Day's High
¥114
Day's Low
¥107
Volume
3,634,800
Avg. Vol
907,222
52-wk High
¥175
52-wk Low
¥105

Yamaji, Hiroshi 

Mr. Hiroshi Yamaji has been serving as Director in OncoTherapy Science, Inc. since June 2005. He is holding directorship in an affiliated company and a subsidiary. He joined the Company in February 2003. His previous titles include Director of Development and Director of Business Development. He used to work in a few companies, including Sankyo Co., Ltd., Eli Lilly Japan K.K., sanofi-aventis K.K., GlaxoSmithKline, as well as Pfizer Japan Inc.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --